← Leaderboards
Michael M Lieberman
Hawaii Biotech, Inc.
$4,411,362
Attributed
$4,411,362
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.1M · FY2005–09$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$4,411,362 · 5
By mechanism
R44$4,094,234 · 1
R43$189,420 · 1
P51$127,708 · 3
Top collaborators
No co-investigators on record.
Most similar at Hawaii Biotech, Inc.
Same institution · by research overlap
- David E. Clements$13,267,458
- Axel T Lehrer$10,832,675
- Beth-Ann Coller$10,591,331
- Eileen T Nakano$1,451,180
- Carolyn Louise Weeks-Levy$4,249,162
Others in their field
Top investigators on “Recombinant Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$132,165,789
- Barton F Haynes · Duke University$119,908,001
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Larry Arthur$44,832,982
- John P Moore · Weill Medical College Of Cornell Univ$36,733,380
- Wayne A. Hendrickson · Rutgers The St Univ Of Nj New Brunswick$34,072,238
Research focus
Recombinant ProteinsWest Nile VirusVaccine DevelopmentHamstersImmunoaffinity ChromatographySourceResearch PersonnelStructural ProteinInstitutionRecombinantsAnimalsFundingComputer Retrieval Of Information On Scientific Projects DatabaseGrantResearch And DevelopmentImmunogenicityAntigensDisease ModelAnimal ModelPrimatesNonhuman PrimateLaboratory MouseClinical TrialsPre-Clinical Research
Grant awards (7)
WEST NILE VIRUS RECOMBINANT SUBUNIT VACCINE: PROTECTION OF NONHUMAN PRIMATES$20,819
P51 · FY2009 · RR · contact PI
WEST NILE VIRUS RECOMBINANT SUBUNIT VACCINE: PROTECTION OF NONHUMAN PRIMATES$20,111
P51 · FY2008 · RR · contact PI
WEST NILE VIRUS RECOMBINANT SUBUNIT VACCINE: PROTECTION OF NONHUMAN PRIMATES$86,778
P51 · FY2007 · RR · contact PI
Recombinant Subunit Vaccine/Prevention of West Nile Vir*$2,039,391
R44 · FY2005 · NS
Recombinant Subunit Vaccine/Prevention of West Nile Vir*$100,000
R44 · FY2005 · NS
Recombinant Subunit Vaccine/Prevention of West Nile Vir*$1,954,843
R44 · FY2004 · NS
Development of a Subunit Vaccine for West Nile$189,420
R43 · FY2003 · AI